Research

Communication and Advancement Awards Report Fiscal Year 2001
Medical Center Area
Medicine
Psychiatry

Primary Total: $487,997.
 Collaborative Total: $2,721,972.

ALFRED YOUNG/JIMMI HATTON-KOLPEK/JOHN RANSEEN
* A Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Single Intravenous Dose of CP-101,606 in Subjects with Severe Head Injury, (461723), Pfizer Inc, $72,740.00

ALLEN BRENZEL
Department of Social Services, (464109), Eastern KY Univ, $92,817.00

ALLEN BRENZEL/HANS KAAK
Multidimensional Assessment of At-Risk Families, (464124), KY Families and Children Cab, $100,000.00

CARL LEUKEFELD
* Health Services Use by Chronic Rural Drug Abusers, (461171), Natl Institute on Drug Abuse, $446,928.00

CATHERINE MARTIN
Drug Abuse, Pubertal Hormones, and ADHD in Adolescence, (462352), Natl Institute on Drug Abuse, $117,469.00

CRAIG RUSH/LON HAYS
* Human Cocaine Discrimination Pharmacological Specificity, (463223), Natl Institute on Drug Abuse, $254,236.00

CRAIG RUSH/LON HAYS
* Acute Behavioral Effects and Abuse Potential of a Single Dose of R174710 in Female Drug Abusers, (464654), Janssen Research Fdtn, $41,600.00

CRAIG RUSH/LON HAYS/THOMAS KELLY
* Assessing Abuse Potential in Humans: CNS Stimulants , (464569), Natl Institute on Drug Abuse, $289,767.00

JOHN ASHFORD
* A Single Dose, Open Label, Three Way Crossover, Randomized, Pilot Bioavailability Study of Haloperidol Comparing Intranasal Administration to Intravenous Administration and Intramuscular Administration in Healthy Human Volunteers, (464693), Inhalation Technology Inc, $45,228.00

JOHN ASHFORD
A Randomized Evaluator Blind Study of Olanzapine and Valproic Acid in the Treatment of Agitation in Alzheimer Patients, (463415), Eli Lilly and Company, $16,562.00

JOHN ASHFORD
Olanzapine Versus Risperidone and Placebo in the Treatment of Psychosis and Associated Behavioral Disturbances in Patients with Dementia, (462736), Eli Lilly and Company, $45,266.00

JOSE DE LEON
Cytochrome P450 2D6 Genotyping and Risperidone Response, (464283), Natl Alliance for Research on Schizophrenia and, $50,000.00

JOSE DE LEON
Risperidone Response: Therapeutic Complications from Genetic Variation in Cytochrome P450-2D6 Expression, (463902), Eli Lilly and Company, $62,383.00

JOSE DE LEON
Research Based at Eastern State Hospital, (464579), Dept for Mental Health Mental Retardation Services, $67,000.00

MARK FILLMORE/LON HAYS/CRAIG RUSH
* Cognitive Processes in Cocaine and Polydrug Abuse, (464705), Natl Institute on Drug Abuse, $286,670.00

ROBERT KRAUS
Psychiatry Research and Program Development, (424942), Dept for Mental Health Mental Retardation Services, ($63,500.00)

TK LOGAN/CARL LEUKEFELD/JAMES WALKER
* Alcohol, Violence, and Health Services in Rural Women, (464269), Natl Institute on Alcohol Abuse and Alcoholism, $796,806.00


* Cross-referenced accounts where the project director/s are affiliated with more than one department, college or center
Information Systems
Questions:
 Deborah Davis,  Office of Sponsored Projects Administration, 112 Kinkead Hall, 0057, 257-8311

UK Awards Home    Research    University of Kentucky